7 Lab Tests Reviewed Before an MSC Program

Before any cell-based programme begins, most reputable clinics run a baseline panel. The purpose is partly candidacy screening and partly having a comparison point for later.

These seven categories appear in most pre-programme workups. The exact list is always decided by the treating physician.

Test 1: Complete Blood Count

A full blood count screens for anaemia, infection and platelet abnormalities. Unexpected results here often pause a programme until the cause is understood, since active infection is a standard reason to postpone.

Test 2: Inflammatory Markers

C-reactive protein and erythrocyte sedimentation rate give a rough picture of systemic inflammation. High baseline values may indicate an untreated condition, and they also provide a reference for tracking change afterwards.

Test 3: Liver and Kidney Function

Liver enzymes and renal function determine how the body handles medication and fluid load, and they influence decisions about intravenous protocols. Impaired function does not automatically exclude someone, but it changes planning.

Test 4: Metabolic and Glucose Panel

Fasting glucose and HbA1c matter because chronically high glucose affects healing, immune function and vascular health. In several conditions, correcting glycaemic control first is more useful than proceeding immediately.

Test 5: Infectious Disease Screening

Screening commonly covers hepatitis B, hepatitis C, HIV and syphilis. This is standard practice in cell-based medicine and protects both the patient and the laboratory workflow.

Test 6: Coagulation Profile

Clotting studies are relevant where injections or infusions are planned, particularly for anyone taking anticoagulant or antiplatelet medication. The results guide timing and any medication adjustment, which only the prescribing doctor should make.

Test 7: Condition-Specific Markers

The final group depends on the diagnosis: autoimmune serology, thyroid panels, vitamin D, ferritin, or organ-specific tests. This is where a genuinely individualised workup differs from a fixed package.

Imaging is often requested alongside blood work. See also how programmes are individualised and the clinic's cellular therapy pathway.

Why Baseline Values Matter Later

Without a baseline, any change afterwards is guesswork. Repeating the same panel at follow-up is what turns a subjective impression of improvement into something measurable, which is why the pre-programme workup should never be treated as a formality.

Baseline Panel Overview

Common Questions

Can tests done at home be used?

Often yes, if recent and complete, though the treating clinic decides which results it accepts and what needs repeating.

How recent should results be?

Recency requirements vary by test and by condition, and the treating physician sets the window.

Does an abnormal result end the process?

Not necessarily. Many findings simply change timing, sequencing or the protocol itself.

Are these tests repeated afterwards?

Repeat testing is common at follow-up, because comparison against baseline is the point of running the panel.

Key Takeaway

A serious pre-programme workup covers blood count, inflammation, organ function, metabolic status, infectious screening, clotting and condition-specific markers. It screens for safety and creates the baseline that makes follow-up meaningful.

This article is for general informational and educational purposes only and is not a substitute for personalized medical advice. Always consult a qualified healthcare professional before considering stem cell therapy.

References

• NIH - Laboratory test information
• PubMed - Pre-treatment screening in cell therapy
• ClinicalTrials.gov